---
figid: PMC2670612__nihms101251f2
figtitle: Tumor resistance to EGFR-targeted therapies
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC2670612
filename: nihms101251f2.jpg
figlink: /pmc/articles/PMC2670612/figure/F2/
number: F2
caption: 'A. Transported substrates of P-glycoprotein (P-GP), also known as multidrug
  resistance gene 1 (MDR1), and as ATP binding casette B1 (ABCB1), multidrug resistance
  protein 1 (MRP1)/ABCC1, breast cancer resistance protein (BCRP)/ABCG2 and Ral binding
  protein 1 (RalBP1)/Ral interacting protein, 76 kDa (RLIP76). ABC transporters efflux
  a wide range of xenobiotics from the cell. Among these, erlotinib (erl), gefitinib
  (gef), and imatinib (imb) target EGFR; colchicine (col), doxorubicin (dox), flavopyridol
  (flav), methotrexate (met), paclitaxel (pac) and vinorelbine (vrl) are cytotoxic
  agents commonly used in conjunction with EGFR-targeted therapies. B. EGFR signaling
  mechanisms that regulate efflux pumps. EGFR signaling pathways regulate the expression
  of the P-GP/MDR1, MRP1, BCRP/ABCG2 and RalBP1/RLIP76 transporters. At least three
  ABC transporters are regulated by EGFR via the phosphinositol 3 kinase (PI3K)–v-akt
  murine thymoma viral oncogene homolog (AKT) arm of the EGFR signaling pathway; phosphatase
  and tensin homolog (PTEN) and NF-κB contribute to this regulation. GRB2: growth
  factor receptor-bound protein 2; RALGDS: v-ral simian leukemia viral oncogene homolog
  guanine nucleotide dissociation stimulator; Ras: RAS viral oncogene homolog; SHC:
  v-src sarcoma viral oncogene homology 2 domain-containing protein; SOS-1: son of
  sevenless homolog 1.'
papertitle: Mechanisms of tumor resistance to EGFR-targeted therapies.
reftext: Elizabeth A Hopper-Borge, et al. Expert Opin Ther Targets. ;13(3):339-362.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8992692
figid_alias: PMC2670612__F2
figtype: Figure
redirect_from: /figures/PMC2670612__F2
ndex: de03f980-df0e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2670612__nihms101251f2.html
  '@type': Dataset
  description: 'A. Transported substrates of P-glycoprotein (P-GP), also known as
    multidrug resistance gene 1 (MDR1), and as ATP binding casette B1 (ABCB1), multidrug
    resistance protein 1 (MRP1)/ABCC1, breast cancer resistance protein (BCRP)/ABCG2
    and Ral binding protein 1 (RalBP1)/Ral interacting protein, 76 kDa (RLIP76). ABC
    transporters efflux a wide range of xenobiotics from the cell. Among these, erlotinib
    (erl), gefitinib (gef), and imatinib (imb) target EGFR; colchicine (col), doxorubicin
    (dox), flavopyridol (flav), methotrexate (met), paclitaxel (pac) and vinorelbine
    (vrl) are cytotoxic agents commonly used in conjunction with EGFR-targeted therapies.
    B. EGFR signaling mechanisms that regulate efflux pumps. EGFR signaling pathways
    regulate the expression of the P-GP/MDR1, MRP1, BCRP/ABCG2 and RalBP1/RLIP76 transporters.
    At least three ABC transporters are regulated by EGFR via the phosphinositol 3
    kinase (PI3K)–v-akt murine thymoma viral oncogene homolog (AKT) arm of the EGFR
    signaling pathway; phosphatase and tensin homolog (PTEN) and NF-κB contribute
    to this regulation. GRB2: growth factor receptor-bound protein 2; RALGDS: v-ral
    simian leukemia viral oncogene homolog guanine nucleotide dissociation stimulator;
    Ras: RAS viral oncogene homolog; SHC: v-src sarcoma viral oncogene homology 2
    domain-containing protein; SOS-1: son of sevenless homolog 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - l(3)93Da
  - PDZ-GEF
  - garz
  - RhoGEF64C
  - pbl
  - Ubc7
  - kn
  - crl
  - coi
  - Curl
  - Rpn3
  - Dox-3
  - iav
  - nan
  - AspRS
  - vri
  - Mdr65
  - MRP
  - Rlip
  - Me
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - drk
  - Shc
  - Rgl
  - term
  - Akt
  - Pten
  - Dif
  - dl
  - Rel
  - Pgi
  - MIER1
  - ARHGEF2
  - SLC2A4RG
  - COX1
  - PACC1
  - TRPV2
  - TRPV1
  - VTRNA1-1
  - ABCB1
  - CD9
  - MDM4
  - ABCC1
  - MSH3
  - ABCG2
  - RALBP1
  - REPS1
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - GRB2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - RALGDS
  - AKT1
  - AKT2
  - AKT3
  - PTEN
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CFTR
  - ABCC10
  - GPI
  - GNPDA1
  - Cancer
  - Lung cancer
---
